KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,125.00
-6.00 (-0.53%)
Oct 23, 2026, 3:30 PM JST
KYORIN Pharmaceutical Market Cap
KYORIN Pharmaceutical has a market cap or net worth of 64.63 billion as of October 23, 2026. It is the 15,922nd most valuable company in the world and the 1,208th biggest in Japan. Its market cap has decreased by 21.61% in one year.
Market Cap
64.63B
Enterprise Value
70.92B
Revenue
125.68B
Global Rank
Country Rank
#1,208 Japan
PE Ratio
29.76
ChartMarket Cap Chart
Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 64.63B, an increase of 254.23%. That is a compound annual growth rate of 6.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 64.63B | -26.81% |
| Dec 30, 2025 | 88.30B | 2.13% |
| Dec 30, 2024 | 86.46B | -15.45% |
| Dec 29, 2023 | 102.26B | 3.75% |
| Dec 30, 2022 | 98.56B | -6.82% |
| Dec 30, 2021 | 105.78B | -4.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 199.56B |
| Towa Pharmaceutical | 177.75B |
| Kissei Pharmaceutical | 157.85B |
| Kaken Pharmaceutical | 146.17B |
| Mochida Pharmaceutical | 114.68B |
| Zeria Pharmaceutical | 89.22B |
| ASKA Pharmaceutical Holdings | 57.62B |
| Fuji Pharma | 48.66B |